ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 50 filers reported holding ARCELLX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,098,719 | -27.1% | 643,777 | -35.8% | 2.13% | -39.5% |
| Q2 2023 | $31,683,208 | -17.6% | 1,001,999 | -19.7% | 3.52% | -11.6% |
| Q1 2023 | $38,455,409 | +12.6% | 1,248,147 | +13.2% | 3.98% | -18.7% |
| Q4 2022 | $34,153,808 | +46.8% | 1,102,447 | -11.1% | 4.90% | +55.0% |
| Q3 2022 | $23,273,000 | +41.5% | 1,239,913 | +36.3% | 3.16% | +23.2% |
| Q2 2022 | $16,448,000 | +18.5% | 909,739 | -8.1% | 2.57% | +43.4% |
| Q1 2022 | $13,876,000 | – | 989,739 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
| NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
| Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
| Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
| Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
| Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
| Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
| Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
| Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |